What analgesia strategy is recommended to minimize respiratory depression in patients at risk for airway compromise (e.g., OSA)?

• A. Multimodal analgesia with non-opioid analgesics and regional techniques
• B. High-dose IV opioids
• C. No analgesia
• D. Sole reliance on acetaminophen

Answer: (A)

Minimizing respiratory depression while still delivering effective analgesia is best achieved with multimodal analgesia that lowers opioid exposure. Opioids suppress the brainstem breathing drive and can worsen airway collapse in patients with sleep apnea or other airway risks. By using non-opioid analgesics together with regional techniques, we achieve strong pain control through different mechanisms without relying on high opioid doses. Non-opioid options such as acetaminophen and NSAIDs provide baseline analgesia and anti-inflammatory effects, while regional techniques—like nerve blocks or neuraxial blocks—deliver targeted pain relief at the site of injury or surgical area. This combination reduces the need for systemic opioids, preserving respiratory function, decreasing sedation, and lowering the risk of apnea events.

In contrast, high-dose IV opioids markedly raise the risk of respiratory depression; giving no analgesia leaves the patient in pain and can trigger stress responses that complicate recovery; relying solely on acetaminophen is often insufficient for moderate to severe postoperative pain and does not address the full pain burden or provide the depth of analgesia regional techniques offer.